Capnia Secures $12 Million Series B Financing
Proceeds will fund Phase IIb Migraine Trials

Los Gatos, CA, April 30, 2004

Capnia, a private biomedical product company developing therapeutic products based on its proprietary medical gas delivery platform, announced today that it raised new investment of $12 Million in its Series B financing.  Proceeds from the offering will fully fund the Company's Phase IIb clinical trials for the treatment of migraine as well as continuing development and clinical evaluation of other products.

(Capnia's homepage)

Swedish Injectable Bone Material Company Raises $ 5 Million

The Swedish biotech company Bone Support AB, which has developed a product platform for injectable bone materials, today announced an investment of $5 million in its first external round of financing. The actual share issue was directed towards two top-tier Scandinavian venture investors, InnovationsKapital, Sweden and Teknoinvest, Norway. The investment will cover the development of the company's first product, SpineSupport™, intended for the use in osteoporotic vertebral fractures. Within a short time, SpineSupport™ will enter clinical trials. 

(Bone Support's homepage)

BURLINGAME, California, December 17, 2002 - Angiogenix, Inc. announced today that it has completed the sale of $12 million of its preferred stock. Led by BioAsia Investments, LLC the financing includes new investors, Teknoinvest Management AS, AIG Global Investment Corp., Posco BioVentures and Kenson Ventures, LLC. Existing investors, Asset Management Company and Sunflower Capital Partners, also participated. Albert Cha, M.D., Ph.D., of BioAsia Investments and Steinar J. Engelsen, M.D., M.Sc., of Teknoinvest Management, have joined the Company’s board of directors.

Click here for the whole press release

(Angiogenix homepage)

Optinel Systems Secures $22.4 Million in Financing

New Funds to Solidify Optinel’s First-to-Market Advantage

ANAHEIM, CA¾December 4, 2002—Optinel Systems, a privately held provider of transport systems for the cable television industry, today announced that it has completed its Series B round of funding, totaling $22.4 million. The round was led by Court Square Ventures, Teknoinvest and Birchmere Ventures. SilverHaze Partners, Four Seasons Ventures, the Dinner Club and Isis Capital also participated in the financing round, along with existing Optinel investors, OCG Ventures and Novak Biddle Venture Partners.

Click here for the whole press release 


VentureWire top story on Dec. 5, 2002  
(select the date in upper right corner)

(Optinel homepage)